Advancing Oncology Requires Oncology-Specific Technology
Sagran Moodley, SVP, Chief Innovation and Technology Officer, Ontada
Ontada News: Latest Insights in Oncology Care
In the news
Ontada’s thought leaders are known for their expertise, research, and insights, with contributions in top oncology publications. Join the conversation to stay up-to-date on the latest advancements in cancer care.
Patient Engagement through Communication Platforms (comments by Sagran Moodley)
Grayson Miller, Healthcare IT Today
Dr. Nicholas J Robert of Ontada On The 5 Things Everyone Needs To Know About Cancer
Savio P. Clemente, Authority Magazine
Partnering With Patients: A Collection of Perspectives From ASCO 2023 (Interview with Nicholas J. Robert, MD)
Keira Smith, Oncology Data Advisor
Data Reveal Racial, SDOH Factors Linked to OS Differences in CLL (Interview with Ira Zackon, MD)
Mary Caffrey
The Impact of Racial and Socioeconomic Disparities in Patients With Chronic Lymphocytic Leukemia
Ira Zackon, MD
How Patient Characteristics, SDOH, Impact CLL, SLL Treatment Backdrop (Interview with David J. Andorsky, MD)
Lauren Massaro, Drug Topics
Slideshow: Examining the Treatment Landscape for Chronic Lymphocytic Leukemia
Killian Meara, Drug Topics
Social Determinants of Health May Not Reduce the Likelihood of Receiving Newer Treatments In Some Cases, According to Expert (Interview with David J. Andorsky, MD)
Erin Hunter, Pharmacy Times
Evaluating Effects of Racial Disparities on the Treatment of Patients With Chronic Lymphocytic Leukemia
Ira L Zackon, MD
Dr Andorsky on Real-World Treatment Patterns With BTK Inhibitors in CLL/SLL
David J. Andorsky, MD
Dr David Andorsky on BTK Inhibitor Treatment Patterns and SDOH in CLL, SLL
Jordyn Sava, Rose McNulty, AJMC
Prescribing Patterns Differ for Rural, Urban Patients with CLL or SLL (Interview with David J. Andorsky, MD)
Brielle Benyon, Cure
The Impact of Social Determinants of Health on Use of Germline Genetic Testing for Triple-Negative Breast Cancer
Barb Kunz
Impacting the World with Data & AI: Announcing the Finalists for the 2023 Databricks Data Team for Good Award
Mike Sanky
Epic Leads Medical Oncology EHR Market in Customer Satisfaction
Hannah Nelson, Tech Target
Social Determinants of Health Impact Germline Testing Rates Among Patients With TNBC (Interview with Barb Kuntz)
Jordyn Sava, Rose McNulty, AJMC
Examining Trends of Biomarker Testing With the MYLUNG Study in mNSCLC (Interview with Nicholas J. Robert, MD)
Jordyn Sava, Targeted Oncology
Expert: Improving Disparities in Biomarker Testing Requires Involvement of Multiple Stakeholders
Nicholas Robert, MD
Bringing Real World Data to Clinical Studies: Q&A With Dr. David Cosgrove of Compass Oncology
Mike Hollan, Pharmaceutical Executive
Health IT Vendors to Support USCDI + Cancer Data Elements | Healthcare Innovation
David Raths
McKesson’s Practice Insights Designated as a 2024 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services
Practice Insights
Improving Cancer Care Through Better Electronic Health Records: Voluntary Commitments and Call to Action | OSTP | The White House
White House
Interested in learning more?
Contact us and one of our research solution experts will follow-up with you soon.